Tocqueville Asset Management L.P. Purchases New Shares in Viemed Healthcare, Inc. $VMD

Tocqueville Asset Management L.P. acquired a new stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 342,100 shares of the company’s stock, valued at approximately $3,900,000. Tocqueville Asset Management L.P. owned approximately 0.90% of Viemed Healthcare at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. BlackRock Inc. purchased a new stake in shares of Viemed Healthcare in the second quarter valued at about $54,587,000. Wasatch Advisors LP lifted its position in shares of Viemed Healthcare by 18.4% during the second quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company’s stock valued at $10,683,000 after purchasing an additional 240,346 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in Viemed Healthcare by 3.6% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,447,033 shares of the company’s stock worth $10,751,000 after purchasing an additional 49,962 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Viemed Healthcare by 2.0% during the second quarter. Geode Capital Management LLC now owns 798,515 shares of the company’s stock worth $5,519,000 after purchasing an additional 15,353 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its position in Viemed Healthcare by 101.9% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company’s stock worth $6,550,000 after purchasing an additional 358,863 shares in the last quarter. 74.24% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have commented on VMD. Wall Street Zen lowered shares of Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 15th. Weiss Ratings downgraded Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday. Finally, Freedom Capital lowered Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 5th. Three analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has an average rating of “Hold”.

Viemed Healthcare Stock Performance

NASDAQ:VMD opened at $8.57 on Friday. The company has a market capitalization of $326.43 million, a P/E ratio of 23.81 and a beta of 1.10. The business has a fifty day simple moving average of $11.01 and a two-hundred day simple moving average of $9.87. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.13 and a quick ratio of 1.02. Viemed Healthcare, Inc. has a 1 year low of $6.05 and a 1 year high of $12.61.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings results on Monday, August 3rd. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.05). The firm had revenue of $78.10 million for the quarter, compared to analysts’ expectations of $78.00 million. Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. On average, analysts expect that Viemed Healthcare, Inc. will post 0.42 earnings per share for the current year.

Insider Transactions at Viemed Healthcare

In other Viemed Healthcare news, Director Timothy Smokoff sold 20,000 shares of the stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total transaction of $230,000.00. Following the completion of the transaction, the director owned 75,518 shares in the company, valued at $868,457. This trade represents a 20.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider William Frazier sold 10,000 shares of Viemed Healthcare stock in a transaction dated Thursday, June 25th. The stock was sold at an average price of $11.72, for a total transaction of $117,200.00. Following the completion of the transaction, the insider owned 73,214 shares of the company’s stock, valued at $858,068.08. The trade was a 12.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 20.60% of the company’s stock.

Viemed Healthcare Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.